ArticleJCO global oncology2023

Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting.

Brooke E Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.